Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

Jung B, Staudacher JJ, Beauchamp D.

Gastroenterology. 2017 Jan;152(1):36-52. doi: 10.1053/j.gastro.2016.10.015. Epub 2016 Oct 20. Review.

2.

Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).

Xicola RM, Bontu S, Doyle BJ, Rawson J, Garre P, Lee E, de la Hoya M, Bessa X, Clofent J, Bujanda L, Balaguer F, Castellví-Bel S, Alenda C, Jover R, Ruiz-Ponte C, Syngal S, Andreu M, Carracedo A, Castells A, Newcomb PA, Lindor N, Potter JD, Baron JA, Ellis NA, Caldes T, LLor X.

Carcinogenesis. 2016 Aug;37(8):751-8. doi: 10.1093/carcin/bgw064. Epub 2016 May 27.

3.

Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications.

Poniatowski ŁA, Wojdasiewicz P, Gasik R, Szukiewicz D.

Mediators Inflamm. 2015;2015:137823. doi: 10.1155/2015/137823. Epub 2015 Jan 29. Review.

4.

TGFBR1 and cancer susceptibility.

Pasche B, Pennison MJ, Jimenez H, Wang M.

Trans Am Clin Climatol Assoc. 2014;125:300-12. Review.

5.

TGF-β: duality of function between tumor prevention and carcinogenesis.

Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ.

J Natl Cancer Inst. 2014 Feb;106(2):djt369. doi: 10.1093/jnci/djt369. Review.

6.

Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.

Wang YQ, Qi XW, Wang F, Jiang J, Guo QN.

PLoS One. 2012;7(8):e42899. doi: 10.1371/journal.pone.0042899. Epub 2012 Aug 8. Review.

7.

Debate about TGFBR1 and the susceptibility to colorectal cancer.

Valle L.

World J Gastrointest Oncol. 2012 Jan 15;4(1):1-8. doi: 10.4251/wjgo.v4.i1.1.

8.

Transforming growth factor β signaling pathway associated gene polymorphisms may explain lower breast cancer risk in western Indian women.

Joshi NN, Kale MD, Hake SS, Kannan S.

PLoS One. 2011;6(8):e21866. doi: 10.1371/journal.pone.0021866. Epub 2011 Aug 4.

9.

TGFBR1 signaling and breast cancer.

Moore-Smith L, Pasche B.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):89-95. doi: 10.1007/s10911-011-9216-2. Epub 2011 Apr 5. Review.

10.

Clinical relevance of microsatellite instability in colorectal cancer.

de la Chapelle A, Hampel H.

J Clin Oncol. 2010 Jul 10;28(20):3380-7. doi: 10.1200/JCO.2009.27.0652. Epub 2010 Jun 1.

11.

Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.

Pasche B, Wisinski KB, Sadim M, Kaklamani V, Pennison MJ, Zeng Q, Bellam N, Zimmerman J, Yi N, Zhang K, Baron J, Stram DO, Hayes MG.

J Exp Clin Cancer Res. 2010 May 25;29:57. doi: 10.1186/1756-9966-29-57.

12.

Candidate gene association studies: successes and failures.

Pasche B, Yi N.

Curr Opin Genet Dev. 2010 Jun;20(3):257-61. doi: 10.1016/j.gde.2010.03.006. Epub 2010 Apr 21. Review.

13.

Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.

Zeng Q, Phukan S, Xu Y, Sadim M, Rosman DS, Pennison M, Liao J, Yang GY, Huang CC, Valle L, Di Cristofano A, de la Chapelle A, Pasche B.

Cancer Res. 2009 Jan 15;69(2):678-86. doi: 10.1158/0008-5472.CAN-08-3980.

14.

Role of polymorphisms in Adamantiades-Behçet's disease.

Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B.

J Rheumatol. 2008 Dec;35(12):2376-8. Epub 2008 Oct 15.

15.

Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.

Dutt SS, Chen N, Darbary HK, Swede H, Petrelli NJ, Stoler DL, Anderson GR.

Mutat Res. 2008 Oct 14;645(1-2):27-32. doi: 10.1016/j.mrfmmm.2008.08.003. Epub 2008 Aug 20.

16.

Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer.

Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A.

Science. 2008 Sep 5;321(5894):1361-5. doi: 10.1126/science.1159397. Epub 2008 Aug 14.

17.

Recent advances in breast cancer genetics.

Pasche B.

Cancer Treat Res. 2008;141:1-10. Review. No abstract available.

18.

Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.

Bian Y, Knobloch TJ, Sadim M, Kaklamani V, Raji A, Yang GY, Weghorst CM, Pasche B.

Hum Mol Genet. 2007 Dec 15;16(24):3128-35. Epub 2007 Sep 21.

19.

TGF-beta signaling alterations and susceptibility to colorectal cancer.

Xu Y, Pasche B.

Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R14-20. Review.

20.

Role of transforming growth factor-beta in hematologic malignancies.

Dong M, Blobe GC.

Blood. 2006 Jun 15;107(12):4589-96. Epub 2006 Feb 16. Review.

Supplemental Content

Support Center